| 1 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D09916
D09916
|
Ivacaftor
| [1] 299 299 |
| 2 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D10134
D10134
|
Lumacaftor
| [1] 299 299 |
| 3 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D11041
D11041
|
Tezacaftor
| [1] 299 299 |
| 4 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D11423
D11423
|
Deutivacaftor
| [1] 299 299 |
| 5 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D11507
D11507
|
Elexacaftor
| [1] 299 299 |
| 6 |
CFTR
| [4] Tight junction Tight junction, Gastric acid secretion, Pancreatic secretion, Vibrio cholerae infection | D11724
D11724
|
Galicaftor
| [1] 299 299 |
| 7 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00113
D00113
|
Atropine
| [2] 2 2, 299 |
| 8 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00138
D00138
|
Scopolamine
| [1] 2 2 |
| 9 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00270
D00270
|
Chlorpromazine
| [1] 254 254 |
| 10 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00397
D00397
|
Tropicamide
| [3] 6 6, 13, 19 |
| 11 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00465
D00465
|
Oxybutynin
| [3] 6 6, 13, 53 |
| 12 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00481
D00481
|
Propantheline
| [1] 26 26 |
| 13 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00525
D00525
|
Pilocarpine
| [3] 6 6, 53, 299 |
| 14 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00646
D00646
|
Tolterodine
| [2] 17 17, 53 |
| 15 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00661
D00661
|
Cevimeline
| [1] 53 53 |
| 16 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00722
D00722
|
Oxybutynin
| [3] 6 6, 13, 53 |
| 17 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00765
D00765
|
Rocuronium
| [1] 296 296 |
| 18 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00787
D00787
|
Trihexyphenidyl
| [2] 5 5, 6 |
| 19 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D00789
D00789
|
Chlorpromazine
| [1] 254 254 |
| 20 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D01000
D01000
|
Bethanechol
| [1] 98 98 |
| 21 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D01077
D01077
|
Atropine
| [2] 2 2, 299 |
| 22 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D01148
D01148
|
Tolterodine
| [2] 17 17, 53 |
| 23 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D01269
D01269
|
Solifenacin
| [3] 6 6, 13, 53 |
| 24 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D01699
D01699
|
Darifenacin
| [2] 6 6, 13 |
| 25 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D02069
D02069
|
Atropine
| [2] 2 2, 299 |
| 26 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D02200
D02200
|
Pilocarpine
| [3] 6 6, 53, 299 |
| 27 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D02212
D02212
|
Ipratropium
| [2] 6 6, 86 |
| 28 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D03011
D03011
|
Atropine
| [2] 2 2, 299 |
| 29 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D03274
D03274
|
Chlorpromazine
| [1] 254 254 |
| 30 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D03654
D03654
|
Darifenacin
| [2] 6 6, 13 |
| 31 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D03814
D03814
|
Atropine
| [2] 2 2, 299 |
| 32 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D04034
D04034
|
Chlorpromazine
| [1] 254 254 |
| 33 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D05478
D05478
|
Pilocarpine
| [3] 6 6, 53, 299 |
| 34 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D07226
D07226
|
Fesoterodine
| [1] 6 6 |
| 35 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D07667
D07667
|
Cevimeline
| [1] 53 53 |
| 36 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D08441
D08441
|
Propiverine
| [1] 226 226 |
| 37 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D08522
D08522
|
Solifenacin
| [3] 6 6, 13, 53 |
| 38 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D08638
D08638
|
Trihexyphenidyl
| [2] 5 5, 6 |
| 39 |
CHRM3
| [8] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases | D11383
D11383
|
Blarcamesine
| [1] 156 156 |
| 40 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D00295
D00295
|
Cimetidine
| [2] 2 2, 254 |
| 41 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D00318
D00318
|
Famotidine
| [7] 6 6, 46, 61, 86, 98, 107, 300 |
| 42 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D00422
D00422
|
Ranitidine
| [2] 13 13, 65 |
| 43 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D00673
D00673
|
Ranitidine
| [2] 13 13, 65 |
| 44 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D03503
D03503
|
Cimetidine
| [2] 2 2, 254 |
| 45 |
HRH2
| [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Gastric acid secretion | D08040
D08040
|
Histamine
| [1] 13 13 |
| 46 |
KCNQ1
| [4] Gastric acid secretion Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection | D00636
D00636
|
Amiodarone
| [2] 28 28, 127 |
| 47 |
KCNQ1
| [4] Gastric acid secretion Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection | D02910
D02910
|
Amiodarone
| [2] 28 28, 127 |
| 48 |
KCNQ1
| [4] Gastric acid secretion Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection | D09569
D09569
|
Ezogabine
| [2] 2 2, 144 |
| 49 |
ATP1A1
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00297
D00297
|
Digitoxin
| [1] 299 299 |
| 50 |
ATP1A1
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
| 51 |
ATP1A2
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00297
D00297
|
Digitoxin
| [1] 299 299 |
| 52 |
ATP1A2
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
| 53 |
ATP1A3
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00297
D00297
|
Digitoxin
| [1] 299 299 |
| 54 |
ATP1A3
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
| 55 |
ATP1A4
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00297
D00297
|
Digitoxin
| [1] 299 299 |
| 56 |
ATP1A4
| [9] Insulin secretion Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Mineral absorption | D00298
D00298
|
Digoxin
| [3] 8 8, 46, 210 |
| 57 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00355
D00355
|
Lansoprazole
| [7] 63 63, 71, 85, 98, 166, 222, 299 |
| 58 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00455
D00455
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 59 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00724
D00724
|
Rabeprazole
| [2] 2 2, 51 |
| 60 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D01207
D01207
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 61 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D01984
D01984
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 62 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D02593
D02593
|
Pantoprazole
| [2] 13 13, 65 |
| 63 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D04056
D04056
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 64 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05259
D05259
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 65 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05261
D05261
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 66 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05353
D05353
|
Pantoprazole
| [2] 13 13, 65 |
| 67 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D07917
D07917
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 68 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D08463
D08463
|
Rabeprazole
| [2] 2 2, 51 |
| 69 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D08903
D08903
|
Dexlansoprazole
| [1] 98 98 |
| 70 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D09339
D09339
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 71 |
ATP4A
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D11784
D11784
|
Vonoprazan
| [2] 63 63, 98 |
| 72 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00355
D00355
|
Lansoprazole
| [7] 63 63, 71, 85, 98, 166, 222, 299 |
| 73 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00455
D00455
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 74 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D00724
D00724
|
Rabeprazole
| [2] 2 2, 51 |
| 75 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D01207
D01207
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 76 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D01984
D01984
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 77 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D02593
D02593
|
Pantoprazole
| [2] 13 13, 65 |
| 78 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D04056
D04056
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 79 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05259
D05259
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 80 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05261
D05261
|
Omeprazole
| [16] 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
| 81 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D05353
D05353
|
Pantoprazole
| [2] 13 13, 65 |
| 82 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D07917
D07917
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 83 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D08463
D08463
|
Rabeprazole
| [2] 2 2, 51 |
| 84 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D08903
D08903
|
Dexlansoprazole
| [1] 98 98 |
| 85 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D09339
D09339
|
Esomeprazole
| [8] 13 13, 46, 86, 98, 107, 113, 298, 299 |
| 86 |
ATP4B
| [3] Oxidative phosphorylation Oxidative phosphorylation, Metabolic pathways, Gastric acid secretion | D11784
D11784
|
Vonoprazan
| [2] 63 63, 98 |
| 87 |
SSTR2
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Growth hormone synthesis, secretion and action, Gastric acid secretion | D00442
D00442
|
Octreotide
| [7] 67 67, 75, 84, 85, 89, 193, 227 |
| 88 |
SSTR2
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Growth hormone synthesis, secretion and action, Gastric acid secretion | D06495
D06495
|
Octreotide
| [7] 67 67, 75, 84, 85, 89, 193, 227 |
| 89 |
SSTR2
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Growth hormone synthesis, secretion and action, Gastric acid secretion | D07431
D07431
|
Somatostatin
| [2] 67 67, 78 |
| 90 |
SSTR2
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Growth hormone synthesis, secretion and action, Gastric acid secretion | D10147
D10147
|
Pasireotide
| [3] 67 67, 74, 75 |
| 91 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D00218
D00218
|
Acetazolamide
| [8] 13 13, 86, 90, 115, 154, 155, 225, 230 |
| 92 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D00518
D00518
|
Diclofenamide
| [1] 114 114 |
| 93 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D00537
D00537
|
Topiramate
| [6] 6 6, 97, 140, 144, 156, 193 |
| 94 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D00653
D00653
|
Dorzolamide
| [1] 90 90 |
| 95 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D01196
D01196
|
Acetazolamide
| [8] 13 13, 86, 90, 115, 154, 155, 225, 230 |
| 96 |
CA2
| [5] Nitrogen metabolism Nitrogen metabolism, Metabolic pathways, Proximal tubule bicarbonate reclamation, Gastric acid secretion, Pancreatic secretion | D07871
D07871
|
Dorzolamide
| [1] 90 90 |